Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study ; volume:7 ; number:3 ; day:12 ; month:8 ; year:2016 ; pages:561-573 ; date:9.2016
Diabetes therapy ; 7, Heft 3 (12.8.2016), 561-573, 9.2016
- Urheber
-
Lak, Vincent
- Beteiligte Personen und Organisationen
-
Svensson, Ann-Marie
Miftaraj, Mervete
Franzen, Stefan
Eliasson, Björn
SpringerLink (Online service)
- DOI
-
10.1007/s13300-016-0191-x
- URN
-
urn:nbn:de:1111-201610062518
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lak, Vincent
- Svensson, Ann-Marie
- Miftaraj, Mervete
- Franzen, Stefan
- Eliasson, Björn
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct-acting antivirals and visceral leishmaniasis: a case report
Medications that interact with direct-acting oral anticoagulant exposure
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs among individuals with type 2 diabetes: a nation-wide observational cohort study
A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Direct-acting antivirals and visceral leishmaniasis: a case report
Medications that interact with direct-acting oral anticoagulant exposure
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs among individuals with type 2 diabetes: a nation-wide observational cohort study
A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Direct-acting antivirals and visceral leishmaniasis: a case report
Medications that interact with direct-acting oral anticoagulant exposure
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs among individuals with type 2 diabetes: a nation-wide observational cohort study
A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®